Compare INAB & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INAB | HHS |
|---|---|---|
| Founded | 2016 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 21.2M |
| IPO Year | 2020 | 1994 |
| Metric | INAB | HHS |
|---|---|---|
| Price | $1.82 | $2.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 35.9K | 1.7K |
| Earning Date | 03-12-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.35 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $159,570,000.00 |
| Revenue This Year | N/A | $6.54 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.12 | $2.33 |
| 52 Week High | $4.20 | $5.39 |
| Indicator | INAB | HHS |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 30.50 |
| Support Level | $1.52 | $2.33 |
| Resistance Level | $2.15 | $3.03 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 47.06 | 14.36 |
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.